Literature DB >> 32797360

Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus.

Manman Liu1,2, Junli Liu3, Xiaoyan Zhang1, Yichuan Xiao3, Gengru Jiang1, Xinfang Huang4,5.   

Abstract

OBJECTIVES: Decreased natural killer (NK) cells have been reported in systemic lupus erythematosus (SLE) patients. However, the role of NK cells in the pathogenesis of SLE is not well understood. In this study, we aimed to characterize NK cell subsets, phenotypes, and cytokine-secreting functions and investigate the clinical relevance of NK cells in SLE patients.
METHODS: Peripheral blood samples from 81 SLE patients and 59 healthy donors (HDs) were collected. The frequency and phenotype of NK cells were measured by flow cytometry. Intracellular interferon-γ (IFN-γ) production by NK cells was evaluated by flow cytometry after stimulation with interleukin-12 (IL-12) and IL-18.
RESULTS: The percentages of NK cells in the peripheral blood of SLE patients were significantly lower than those in HDs, and the percentages of CD56dim NK cells among total NK cells showed a trend toward decrease. The CD56dim NK cells in SLE patients showed increased production of IFN-γ and displayed relatively activated phenotypic characteristics, including significant increases in NKp44, NKp46, and CD69 and decreased expression of CD16 and CD158a/h/g. Furthermore, CD56dim NK cells in active SLE patients had higher percentages of NKp44+ cells and lower percentages of CD158a/h/g+ cells than those in inactive SLE patients. The percentages of CD158a/h/g+ cells among CD56dim NK cells were negatively correlated with the systemic lupus erythematosus disease activity index (SLEDAI) and positively correlated with C3 and C4 levels.
CONCLUSION: CD56dim NK cells in SLE patients show a reduced proportion tendency among total NK cells and are activated, which partially reflects the disease activity. CD158a/h/g expression on CD56dim NK cells may be considered an index of disease activity. Key Points • In patients with SLE, the proportion of CD56dim NK cells showed a decreased trend and CD56dim NK cells were phenotypically activated which partially reflects the disease activity. • CD158a/h/g expression on CD56dim NK cells were decreased which may be used as an indicator for evaluating disease activity in SLE patients.

Entities:  

Keywords:  CD158a/h/g; CD56dim natural killer cell; Disease activity; Interferon-γ; Phenotype; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2020        PMID: 32797360     DOI: 10.1007/s10067-020-05306-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.

Authors:  Andrea De Maria; Federica Bozzano; Claudia Cantoni; Lorenzo Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.

Authors:  Yenan T Bryceson; Michael E March; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases.

Authors:  B Grzywacz; N Kataria; M R Verneris
Journal:  Leukemia       Date:  2007-02       Impact factor: 11.528

Review 4.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

Review 5.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

6.  Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Authors:  F D Shi; H B Wang; H Li; S Hong; M Taniguchi; H Link; L Van Kaer; H G Ljunggren
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

Review 7.  Natural killer cell biology: an update and future directions.

Authors:  Kerry S Campbell; Jun Hasegawa
Journal:  J Allergy Clin Immunol       Date:  2013-07-30       Impact factor: 10.793

8.  Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

Authors:  Yong-Wook Park; Seung-Jung Kee; Young-Nan Cho; Eun-Hee Lee; Hwa-Youn Lee; Eun-Mi Kim; Min-Ho Shin; Jeong-Jin Park; Tae-Jong Kim; Shin-Seok Lee; Dae-Hyun Yoo; Hyung-Sik Kang
Journal:  Arthritis Rheum       Date:  2009-06

Review 9.  Natural killer cells in human autoimmune disorders.

Authors:  Leslie A Fogel; Wayne M Yokoyama; Anthony R French
Journal:  Arthritis Res Ther       Date:  2013-07-11       Impact factor: 5.156

Review 10.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

View more
  6 in total

Review 1.  The Role of Natural Killer Cells in Autoimmune Diseases.

Authors:  Umut Can Kucuksezer; Esin Aktas Cetin; Fehim Esen; Ilhan Tahrali; Nilgun Akdeniz; Metin Yusuf Gelmez; Gunnur Deniz
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 2.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

3.  High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.

Authors:  Gloria Yiu; Tue Kruse Rasmussen; Brandon L Tsai; Vivian K Diep; David J Haddon; Jennifer Tsoi; Gopika D Miller; Begoña Comin-Anduix; Bent Deleuran; Gay M Crooks; Paul J Utz
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

4.  Single-cell RNA-seq reveals altered NK cell subsets and reduced levels of cytotoxic molecules in patients with ankylosing spondylitis.

Authors:  Conglin Ren; Mingshuang Li; Yang Zheng; Bingbing Cai; Weibin Du; Helou Zhang; Fengqing Wu; Mengsha Tong; Fu Lin; Jinfu Wang; Renfu Quan
Journal:  J Cell Mol Med       Date:  2022-01-06       Impact factor: 5.310

5.  The phenotype of CD3-CD56bright and CD3-CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity.

Authors:  Dwi Soelistyoningsih; Hani Susianti; Handono Kalim; Kusworini Handono
Journal:  Reumatologia       Date:  2022-09-07

Review 6.  Dysregulation of immunity in COVID-19 and SLE.

Authors:  Seyyed Sina Hejazian; Seyyedeh Mina Hejazian; Farahnoosh Farnood; Sima Abedi Azar
Journal:  Inflammopharmacology       Date:  2022-08-26       Impact factor: 5.093

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.